A weight-loss drug that also controls sleep apnea and knee pain: Eli Lilly may have found one

Eli Lilly and its rivals, including Denmark's Novo Nordisk, are in a race to dominate the booming market for obesity and diabetes drugs.

from mint - science https://ift.tt/eI1u3o4
https://ift.tt/VhBKHtd